Skip to content

Prediction of efficacy of PPI treatment on functional dyspepsia by serum pepsinogen values.

Prediction of efficacy of PPI treatment on functional dyspepsia by serum pepsinogen values. - Prediction of efficacy of PPI treatment on functional dyspepsia by serum pepsinogen values.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000017344
Enrollment
200
Registered
2015-05-01
Start date
2013-06-16
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

functional dyspepsia

Interventions

4 week PPI treatment

Sponsors

Division of Gastroenterology, Tohoku University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with functional dyspepsia complaining the symptom for more than 1 month

Exclusion criteria

Exclusion criteria: 1. history of H. pylori eradication 2. taking aspirin or NSAIDs 3. main symptom is reflux 4. irritable bowel symdrome 5. history of abdominal open surgery 6. potential pregnancy 7. potential mental illness 8. serious sytematic diseases 9. PPI usage within 1 month

Design outcomes

Primary

MeasureTime frame
Comparison of proportion of responders to PPI treatment between hyposecretors and non-hyposecretors judged by serum pepsinogen values

Countries

Japan

Contacts

Public ContactKatsunori Iijima

Tohoku University Hospital Division of Gastroenterology

kiijima@med.tohoku.ac.jp022-717-7171

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026